Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date Rheumatology Education Healthcare DisparitiesRelease Date:Education Inflammation & Immunology USA Promotion of the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic BladderRelease Date:Education Internal Medicine Japan Improving Knowledge and Capability to Communicate Information on the Latest Hemophilia TreatmentsRelease Date:Education Rare Disease Japan Equity in Access to Cancer Cachexia Clinical TrialsRelease Date:Quality Improvement Internal Medicine All Infectious Disease FellowshipRelease Date:Fellowship Hospital India Inflammatory Bowel Disease (Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey)Release Date:Fellowship Inflammation & Immunology All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Mayo ClinicReview Process: Expert Review PanelQuality Improvement Rare Disease All 2022 Growth Hormone ResearchRelease Date:Research Rare Disease All Meta-analysis of COVID-19 Vaccine Hesitancy Behavioral & Social Science ResearchRelease Date:Research Vaccines USA New & Emerging Therapies for Atopic Dermatitis for Dermatologists, Allergists, and Advanced Practice ProvidersRelease Date:Education Inflammation & Immunology USA Addressing the Needs of Patients with Mental Health Issues and Inflammatory Bowel DiseasesRelease Date:Quality Improvement Inflammation & Immunology Canada Improving the Care of Patients with Disorders of Impaired GrowthQuality Improvement Rare Disease All